Augmenting Flortaucipir Dosimetry Estimates

This study will obtain data from urine in subjects administered flortaucipir in an Avid-sponsored study to augment the calculation of radiation dosimetry estimates.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Alzheimer's Disease Alzheimer Disease Brain Diseases Central Nervous System Diseases Dementia Mental Disorders Nervous System Diseases Neurocognitive Disorders Neurodegenerative Diseases Tauopathies

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1

Primary location

Molecular NeuroImaging

New Haven, Connecticut, 06510, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Subjects who passed screening in an Avid-sponsored study in which flortaucipir will be administered

Exclusion criteria

Subjects who have withdrawn informed consent
Investigator or sponsor believes it is in the best interest of the subject to be removed from the trials

Treatment and study plan

Flortaucipir F18

Drug

No flortaucipir administered in this study. Subjects received flortaucipir in an Avid-sponsored study.

Other names: 18F-AV-1451, [F-18]T807, LY3191748, Tauvid

Primary outcomes

Urine Analysis - Total Integrated Radioactivity Excreted in Urine

Time frame: 0-360 minutes post injection

Total integrated radioactivity excreted in urine over time will be determined to augment previous radiation dosimetry calculations.

Sponsors and collaborators

Lead sponsor

Avid Radiopharmaceuticals

Industry

Registry information

Official study title

A Multicenter Study to Obtain Data to Assist in Radiation Dosimetry Calculations From Subjects Enrolled in Human Studies Employing 18F-AV-1451

Important dates

Study start: 2015
Primary completion: 2015
Study completion: 2015
First posted: Jan 13, 2015
Registry last updated: Aug 11, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed